This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.
This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
-
Stanford University, Palo Alto, California, United States, 94304
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
Stanford University,
Elizabeth Kidd, MD, PRINCIPAL_INVESTIGATOR, Stanford University
2028-06